Anticardiolipin antibodies: Clinical consequences of "low titers"

Obstetrics and Gynecology

Volumn 87, Issue 4, 1996, Pages 494-500

  Silver, Robert M ^a   Porter, T Flint ^b   Van Leeuween, Ingeborg ^b   Jeng, Gary ^b   Scott, James R ^b   Branch, D Ware ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; DISEASE ASSOCIATION; FEMALE; FETUS DEATH; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SPONTANEOUS ABORTION; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0029938039     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00497-1     Document Type: Article

References (27)

1. Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152-6.
2. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985;313:1322-6.
3. Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GR. Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986;146:2153-6.
4. Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1989;13:486-9.
5. Harris EN. Syndrome of the black swan. Br J Rheumatol 1986;26: 324-6.
6. Alarcon-Segovia D, Deleze M, Oria C, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive cases. Medicine 1989;68: 353-65.
7. Asherson RA, Khamashta MA, Ordi-ros J, Derksen RH, Machin SJ, Barquinero J, et al. The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine 1989;68:366-74.
8. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992;80:614-20.
9. Martin BA, Branch DW, Rodgers GM. The preparation of a partial thromboplastin reagent from bovine brain. Blood Coagul Fibrinolysis 1992;3:287-94.
10. Harris EN. The Second International Anti-cardiolipin Standardization Workshop: The Kingston Anti-phospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990;94:476-84.
11. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: An historic cohort study. Obstet Gynecol 1994;83:372-7.
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. McCarty DJ, ed. Arthritis and allied conditions, 11th ed. Philadelphia: Lea and Febiger, 1989.
14. Everitt BS. Statistical methods for medical investigations. 2nd ed. New York: Edward Arnold, 1994.
15. Boue A, Boue J. Chromosome abnormalities and abortion. In: Holleander A, ed. Basic life sciences physiology and genetics of reproduction. Vol. 4A. New York: Plenum Press, 1974:317.
16. Harris EN. A reassessment of the antiphospholipid syndrome. J Rheumatol 1990;17:733-5.
17. Asherson RA, Cervera R. The antiphospholipid syndrome: A syndrome in evolution. Ann Rheum Dis 1992;51:147-50.
18. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989;161:369-73.
19. Harris EN, Spinnato JA. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991;165:1272-7.
20. Tripplett DA. Antiphospholipid antibodies and thrombosis: A consequence, coincidence, or cause? Arch Pathol Lab Med 1993; 117:78-88.
21. Branch DW, Dudley DJ, Mitchell MD, Creighton KA, Abbott TM, Hammond EH, et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss. Am J Obstet Gynecol 1990;163:210-6.
22. Blank MJ, Cohen V, Toder V, Shoenfeld Y. Induction of experimental antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal antibodies. Proc Natl Acad Sci U S A 1991;88:3069-73.
23. Pierangeli SS, Barker JH, Stikovic D, et al. Effect of human IgG antiphospholipid antibodies on an in vitro thrombosis model in mice. Thromb Haemost (in press; 1996).
24. Rosove MH, Tabsh K, Wasserstrum N, Howard P, Hahn BH, Kalunian KC. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75:630-4.
25. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone to low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-27.
26. Silveira LH, Hubble CL, Jara LJ, Saway S, Martinez-Osuna P, Seleznick MJ, et al. Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. Am J Med 1992;93: 403-11.
27. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993;169:1411-7.